These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 8605971

  • 1. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T, Brice M, Farrer D, Kaushansky K.
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [Abstract] [Full Text] [Related]

  • 2. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM.
    Stem Cells; 1997 Apr; 15(1):18-32. PubMed ID: 9007219
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 4. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ, Mandich D, Bruno E, DiGiusto RK, Fu WC, Sutherland DR, Hoffman R, Tsukamoto A.
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 6. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE, Foster DC, Lok S, Jacobsen SE, Murphy MJ.
    Stem Cells; 1996 Oct; 14 Suppl 1():163-72. PubMed ID: 11012217
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
    Sawai N, Koike K, Ito S, Kurokawa Y, Mwamtemi HH, Kinoshita T, Sakashita K, Higuchi T, Takeuchi K, Shiohara M, Ogami K, Komiyama A.
    Stem Cells; 1999 Oct; 17(1):45-53. PubMed ID: 10215401
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG, Fatrai S, Drayer AL, Tyl MR, Vellenga E, Schuringa JJ.
    Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
    [Abstract] [Full Text] [Related]

  • 9. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T, Kodama I, Horie K, Kato T, Miyazaki H.
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PM.
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [Abstract] [Full Text] [Related]

  • 11. In vitro expansion of CD34+/CD41+ cells from human peripheral blood CD34+/CD41- cells: role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors.
    Koizumi K, Sawada K, Yamaguchi M, Notoya A, Tarumi T, Takano H, Fukada Y, Nishio M, Katagiri E, Yasukouchi T, Sato N, Sekiguchi S, Koike T.
    Exp Hematol; 1998 Nov; 26(12):1140-7. PubMed ID: 9808053
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L, Henschler R, Lecchi L, Rebulla P, Mertelsmann R, Sirchia G.
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow.
    Debili N, Coulombel L, Croisille L, Katz A, Guichard J, Breton-Gorius J, Vainchenker W.
    Blood; 1996 Aug 15; 88(4):1284-96. PubMed ID: 8695846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H, Guilbert LJ, Janowska-Wieczorek A.
    Exp Hematol; 1990 Mar 15; 18(3):174-9. PubMed ID: 2303109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.